Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial
Pernicova I, Kelly S, Ajodha S, et al
Lancet Diabetes Endocrinol. 2020;8(4):278-91
Leggi